References
- Arnt J, Skarsfeldt T. Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence. Neurorpsychopharmacology 1998; 18: 63–101
- Gefvert O, Lundberg T, Wieselgren I M, et al. D 2 and 5HT 2A receptor occupancy of different doses of quetiapine in schizophrenia: a PET study. European Neuropsychopharmacology 2001; 11: 105–110
- Aubry J M, Simon A E, Bertschy G. Possible induction of mania and hypomania by olanzapine and risperidone: a critical review of reported cases. Journal of Clinical Psychiatry 2000; 61: 649–655
- Benazzi F. Quetiapine-associated hypomania in a woman with schizoaffective disorder. Canadian Journal of Psychiatry 2001; 46: 182–183
- Atmaca M, Kuloglu M, Buyukbayram A, Tezcan E. Quetiapine-associated and dose-related hypomania in a woman with schizophrenia. European Psychiatry. 2002; 17: 292–293